Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis
AbstractChronic kidney disease is a major public health problem around the world. Because the kidney plays a role in reducing glycative stress, renal dysfunction results in increased glycative stress. In turn, glycative stress, especially that due to advanced glycated end products (AGEs) and their precursors such as reactive carbonyl compounds, exacerbates chronic kidney disease and is related to premature aging in chronic kidney disease, whether caused by diabetes mellitus or otherwise. Factors which hinder a sufficient reduction in glycative stress include the inhibition of anti-glycation enzymes (e.g., GLO-1), as well as pathogenically activated endoplasmic reticulum (ER) stress and hypoxia in the kidney. Promising strategies aimed at halting the vicious cycle between chronic kidney disease and increases in glycative stress include the suppression of AGE accumulation in the body and the enhancement of GLO-1 to strengthen the host defense machinery against glycative stress. View Full-Text
Share & Cite This Article
Hirakawa, Y.; Inagi, R. Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis. Int. J. Mol. Sci. 2017, 18, 174.
Hirakawa Y, Inagi R. Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis. International Journal of Molecular Sciences. 2017; 18(1):174.Chicago/Turabian Style
Hirakawa, Yosuke; Inagi, Reiko. 2017. "Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis." Int. J. Mol. Sci. 18, no. 1: 174.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.